Profilo
Dakota Gallivan è Chief Healthcare Compliance Officer & VP presso Reata Pharmaceuticals, Inc. Il signor Gallivan ha precedentemente occupato la posizione di Consigliere per la conformità presso Pharmacyclics LLC. Il signor Gallivan si è laureato al St. Francis College e si è laureato alla Seton Hall University School of Law.
Precedenti posizioni note di Dakota Gallivan
| Società | Posizione | Fine |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | Compliance Officer | 26/09/2023 |
| DERMIRA, INC. | General Counsel | 01/01/2020 |
| PHARMACYCLICS, INC. | General Counsel | 01/04/2018 |
| Medivation, Inc. /Old/ | General Counsel | 01/04/2017 |
| PFIZER, INC. | General Counsel | 01/04/2017 |
Formazione di Dakota Gallivan
| St. Francis College | Undergraduate Degree |
| Seton Hall University School of Law | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
| Medivation, Inc. /Old/ | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
- Borsa valori
- Insiders
- Dakota Gallivan
